The Minnesota Legislature in 2023 created the Psychedelic Medicine Task Force, which was charged with evaluating whether we ...

The question of whether to create a psilocybin therapeutic access program is not about if, but how it will be implemented.” ...

How do psychedelics help people heal from depression, anxiety, addiction, and other mental health challenges? While much attention has been paid to neurochemical mechanisms, a simple ski analogy — ...

A peer-reviewed viewpoint article published in Psychedelics by Prof. Xiaohui Wang and colleagues examines the therapeutic potential of psychedelic substances for treating stress-related psychiatric ...

A new study in mice suggests psychedelics make the brain more likely to "see" images from memory rather than what's actually in front of it. Long before modern laboratory testing, indigenous cultures ...

Since being diagnosed with depression in 1995, Leonie Schneider has been prescribed antidepressants for over 24 years. “To be ...

Psychedelics are a class of hallucinogenic compounds that have emerged as a promising form of treatment for neuropsychiatric disorders. Recent work suggests psychedelics can enhance structural and ...

The Food and Drug Administration has announced it will offer “ultra-fast review” to two psychedelic drugs: psilocybin and methylone. The FDA has also authorized initial testing of a drug related to ...

Understanding exactly how psychedelics promote new connections in the brain is critical to developing targeted, non-hallucinogenic therapeutics that can treat neurodegenerative and neuropsychiatric ...

Psychedelics activate the 5-HT2A receptor, upregulate brain-derived neurotrophic factor, and enhance synaptic plasticity, leading to therapeutic potential for stress and psychiatric disorders.